CN103160466A - 由万能干细胞所分化的神经上皮细胞的培养方法及培养基 - Google Patents
由万能干细胞所分化的神经上皮细胞的培养方法及培养基 Download PDFInfo
- Publication number
- CN103160466A CN103160466A CN2012101855370A CN201210185537A CN103160466A CN 103160466 A CN103160466 A CN 103160466A CN 2012101855370 A CN2012101855370 A CN 2012101855370A CN 201210185537 A CN201210185537 A CN 201210185537A CN 103160466 A CN103160466 A CN 103160466A
- Authority
- CN
- China
- Prior art keywords
- cell
- nerve
- neuroepithelial
- inducing
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 80
- 238000012258 culturing Methods 0.000 title claims abstract description 4
- 210000000461 neuroepithelial cell Anatomy 0.000 title claims description 81
- 238000000034 method Methods 0.000 title claims description 27
- 230000004069 differentiation Effects 0.000 claims abstract description 60
- 210000005036 nerve Anatomy 0.000 claims abstract description 44
- 239000003112 inhibitor Substances 0.000 claims abstract description 35
- 239000000556 agonist Substances 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 25
- 230000001131 transforming effect Effects 0.000 claims abstract description 11
- 230000006698 induction Effects 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 43
- 230000001939 inductive effect Effects 0.000 claims description 43
- 230000010261 cell growth Effects 0.000 claims description 22
- 239000000835 fiber Substances 0.000 claims description 22
- 239000003102 growth factor Substances 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 108050003627 Wnt Proteins 0.000 claims description 13
- 102000013814 Wnt Human genes 0.000 claims description 13
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 13
- 108091000080 Phosphotransferase Proteins 0.000 claims description 12
- 102000020233 phosphotransferase Human genes 0.000 claims description 12
- 230000004913 activation Effects 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 238000004114 suspension culture Methods 0.000 claims description 6
- 229940122798 Bone morphogenetic protein inhibitor Drugs 0.000 claims description 5
- 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 claims description 5
- 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 claims description 5
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 claims description 5
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 claims description 5
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 claims description 5
- 101700032040 SMAD1 Proteins 0.000 claims description 5
- 108010059616 Activins Proteins 0.000 claims description 4
- 102000005606 Activins Human genes 0.000 claims description 4
- 239000000488 activin Substances 0.000 claims description 4
- 239000006143 cell culture medium Substances 0.000 claims description 4
- 108700007229 noggin Proteins 0.000 claims description 4
- 102000045246 noggin Human genes 0.000 claims description 4
- 108091008794 FGF receptors Proteins 0.000 claims description 3
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 3
- 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 claims description 3
- 102100023132 Transcription factor Jun Human genes 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 3
- 102000006533 chordin Human genes 0.000 claims description 3
- 108010008846 chordin Proteins 0.000 claims description 3
- XHBVYDAKJHETMP-UHFFFAOYSA-N dorsomorphin Chemical compound C=1C=C(C2=CN3N=CC(=C3N=C2)C=2C=CN=CC=2)C=CC=1OCCN1CCCCC1 XHBVYDAKJHETMP-UHFFFAOYSA-N 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 230000001537 neural effect Effects 0.000 abstract description 22
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000001172 regenerating effect Effects 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 210000002919 epithelial cell Anatomy 0.000 abstract 4
- 239000001963 growth medium Substances 0.000 abstract 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 abstract 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 abstract 1
- 229940126864 fibroblast growth factor Drugs 0.000 abstract 1
- 210000003061 neural cell Anatomy 0.000 abstract 1
- 238000010166 immunofluorescence Methods 0.000 description 22
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 11
- 102100020871 Forkhead box protein G1 Human genes 0.000 description 7
- 101710087964 Forkhead box protein G1 Proteins 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 210000004129 prosencephalon Anatomy 0.000 description 6
- 102000000905 Cadherin Human genes 0.000 description 5
- 108050007957 Cadherin Proteins 0.000 description 5
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 5
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 5
- 101100310657 Mus musculus Sox1 gene Proteins 0.000 description 5
- 108050000637 N-cadherin Proteins 0.000 description 5
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 5
- 101150081664 PAX6 gene Proteins 0.000 description 5
- 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 4
- 102000008730 Nestin Human genes 0.000 description 4
- 108010088225 Nestin Proteins 0.000 description 4
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000005055 nestin Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 241000220317 Rosa Species 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 102000038030 PI3Ks Human genes 0.000 description 2
- 108091007960 PI3Ks Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 210000002242 embryoid body Anatomy 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical group C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- DDLZLOKCJHBUHD-WAVHTBQISA-N 6-bromoindirubin-3'-oxime Chemical compound O=C/1NC2=CC(Br)=CC=C2C\1=C\1/C(=N/O)/C2=CC=CC=C2N/1 DDLZLOKCJHBUHD-WAVHTBQISA-N 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 102000052547 Wnt-1 Human genes 0.000 description 1
- 108700020987 Wnt-1 Proteins 0.000 description 1
- -1 Wnt3a Proteins 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 231100000704 bioconcentration Toxicity 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- SAQUSDSPQYQNBG-UHFFFAOYSA-N chembl355496 Chemical compound N1C2=CC=CC=C2C(N=O)=C1C1=C(O)NC2=CC(Br)=CC=C21 SAQUSDSPQYQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001988 somatic stem cell Anatomy 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000003014 totipotent stem cell Anatomy 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Abstract
Description
组成 | 含量 |
神经干细胞培养基(Neurobasal medium;GIBCO) | 500mL |
N2神经细胞生长添加剂(GIBCO) | 5mL |
非必须胺基酸(Sigma) | 5mL |
肝素(1mg/mL) | 1mL |
一级抗体 | 一抗宿主 | 稀释浓度 | 二级抗体 |
Oct4 | Goat | 1:200 | Cy3,FITC |
Sox2 | Rabbit | 500 | Cy3,FITC |
Nanog | Rabbit | 500 | Cy3,FITC |
Nestin | Rabbit | 1:200 | Cy3,FITC |
Pax6 | Rabbit | 1:200 | Cy3,FITC |
Sox1 | Goat | 1:200 | Cy3,FITC |
Zic-1 | Rabbit | 1:200 | Cy3,FITC |
N-cadherin | Mouse | 1:200 | Cy3,FITC |
ZO-1 | Rabbit | 1:100 | Cy3,FITC |
BF-1 | Rabbit | 1:100 | Cy3,FITC |
Tuj1 | mouse | 1:500 | Cy3,FITC |
Oct4 | nanog | Sox2 | Nestin | Zo-1 | N-cadherin | Sox1 | Pax6 | Zic-1 | BF1 |
6.7% | 0% | 98% | 93.3% | 98% | 98% | 87.9% | %67 | 89% | 95.6% |
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW100146179 | 2011-12-14 | ||
TW100146179A TWI493034B (zh) | 2011-12-14 | 2011-12-14 | Neuronal epithelial cells differentiated by universal stem cells and the medium used and their differentiation methods |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103160466A true CN103160466A (zh) | 2013-06-19 |
CN103160466B CN103160466B (zh) | 2015-06-03 |
Family
ID=48584002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210185537.0A Active CN103160466B (zh) | 2011-12-14 | 2012-06-06 | 由万能干细胞所分化的神经上皮细胞的培养方法及培养基 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130157358A1 (zh) |
JP (1) | JP5823925B2 (zh) |
CN (1) | CN103160466B (zh) |
TW (1) | TWI493034B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015143622A1 (zh) * | 2014-03-25 | 2015-10-01 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
CN106479977A (zh) * | 2016-08-29 | 2017-03-08 | 广东依浦赛生物科技有限公司 | 人源iPS干细胞体外定向分化为神经细胞的试剂盒及方法 |
CN109294975A (zh) * | 2018-10-23 | 2019-02-01 | 山东华思生物科技有限公司 | 一种干细胞药物筛选方法 |
CN113166219A (zh) * | 2018-09-28 | 2021-07-23 | 纪念斯隆-凯特琳癌症中心 | 干细胞衍生的人小神经胶质细胞、制备方法及使用方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201703600YA (en) * | 2014-12-05 | 2017-06-29 | Meridigen Biotech Co Ltd | Method of distinguishing mesenchymal stem cells |
WO2016117139A1 (ja) * | 2015-01-20 | 2016-07-28 | タカラバイオ株式会社 | 神経系細胞の製造方法 |
WO2016118824A1 (en) | 2015-01-22 | 2016-07-28 | Regenerative Medical Solutions, Inc. | Markers for differentiation of stem cells into differentiated cell populations |
CN111793608B (zh) * | 2017-07-28 | 2022-05-17 | 杨涛 | 定向诱导hiPSC分化为神经细胞体系的HS5条件培养基 |
CN114292807A (zh) * | 2021-12-28 | 2022-04-08 | 深圳市夏同生物医药科技有限公司 | 一种外泌体的提取方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010108005A2 (en) * | 2009-03-18 | 2010-09-23 | University Of Georgia Research Foundation | Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
CN101914493A (zh) * | 2010-07-16 | 2010-12-15 | 山东省齐鲁干细胞工程有限公司 | 脐带间充质干细胞分化为神经细胞的诱导方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005123902A1 (ja) * | 2004-06-18 | 2005-12-29 | Riken | 無血清浮遊培養による胚性幹細胞の神経分化誘導法 |
US20110305672A1 (en) * | 2008-07-25 | 2011-12-15 | University Of Georgia Research Foundation, Inc. | COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME |
WO2010108008A2 (en) * | 2009-03-18 | 2010-09-23 | University Of Georgia Research Foundation | Bsc cell differentiation and use in therapy |
US10119120B2 (en) * | 2009-08-12 | 2018-11-06 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
KR101168053B1 (ko) * | 2009-11-06 | 2012-07-24 | 연세대학교 산학협력단 | 효율적이고 보편적인 전분화능 줄기세포의 신경세포 분화 유도방법 |
CA2815223A1 (en) * | 2010-10-26 | 2012-07-19 | Case Western Reserve University | Differentiation methods for production of glial cell populations |
-
2011
- 2011-12-14 TW TW100146179A patent/TWI493034B/zh active
-
2012
- 2012-05-31 US US13/485,914 patent/US20130157358A1/en not_active Abandoned
- 2012-06-06 CN CN201210185537.0A patent/CN103160466B/zh active Active
- 2012-06-20 JP JP2012139022A patent/JP5823925B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010108005A2 (en) * | 2009-03-18 | 2010-09-23 | University Of Georgia Research Foundation | Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
CN101914493A (zh) * | 2010-07-16 | 2010-12-15 | 山东省齐鲁干细胞工程有限公司 | 脐带间充质干细胞分化为神经细胞的诱导方法 |
Non-Patent Citations (1)
Title |
---|
MATTHEW T. PANKRATZ ET AL: "Directed Neural Differentiation of Human Embryonic Stem Cells via an Obligated Primitive Anterior Stage", 《STEM CELLS》, vol. 25, no. 6, 30 June 2007 (2007-06-30), pages 1511 - 1520, XP055201990, DOI: doi:10.1634/stemcells.2006-0707 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015143622A1 (zh) * | 2014-03-25 | 2015-10-01 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
CN105121633A (zh) * | 2014-03-25 | 2015-12-02 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
CN105121633B (zh) * | 2014-03-25 | 2018-05-01 | 云南中科灵长类生物医学重点实验室 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
CN106479977A (zh) * | 2016-08-29 | 2017-03-08 | 广东依浦赛生物科技有限公司 | 人源iPS干细胞体外定向分化为神经细胞的试剂盒及方法 |
CN113166219A (zh) * | 2018-09-28 | 2021-07-23 | 纪念斯隆-凯特琳癌症中心 | 干细胞衍生的人小神经胶质细胞、制备方法及使用方法 |
CN109294975A (zh) * | 2018-10-23 | 2019-02-01 | 山东华思生物科技有限公司 | 一种干细胞药物筛选方法 |
Also Published As
Publication number | Publication date |
---|---|
US20130157358A1 (en) | 2013-06-20 |
TWI493034B (zh) | 2015-07-21 |
JP2013123436A (ja) | 2013-06-24 |
CN103160466B (zh) | 2015-06-03 |
JP5823925B2 (ja) | 2015-11-25 |
TW201323610A (zh) | 2013-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103160466B (zh) | 由万能干细胞所分化的神经上皮细胞的培养方法及培养基 | |
Kim et al. | Alginate microcapsule as a 3D platform for the efficient differentiation of human embryonic stem cells to dopamine neurons | |
Burridge et al. | Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes | |
CN109880800A (zh) | 一种中脑多巴胺能神经前体细胞及其制备方法和应用 | |
CN108103021B (zh) | 一种新型人源诱导型神经干细胞的制备方法及其应用 | |
Ferrari et al. | Isolation of neural stem cells from neural tissues using the neurosphere technique | |
Suszynska et al. | The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues | |
CN101831401A (zh) | 体外诱导间充质干细胞分化为神经干细胞的方法 | |
CN103667349B (zh) | 一种高效获取猪诱导性多能干细胞的方法 | |
US20170283768A1 (en) | Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel | |
CN106350521A (zh) | 一种als患者特异性运动神经元的制备方法 | |
KR102025474B1 (ko) | 에티오나마이드를 이용한 줄기세포 이동성 향상 방법 | |
Kumar et al. | Two-step induction of trabecular meshwork cells from induced pluripotent stem cells for glaucoma | |
CN102559593A (zh) | 一种从人胚胎干细胞分化成神经细胞的方法 | |
US10472607B2 (en) | Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells | |
CN105106240A (zh) | 一种新型干细胞制剂及其在血管介入治疗脑卒中的用途 | |
CN102206611B (zh) | 一种羊水源性神经干细胞的分离培养方法 | |
JP5833126B2 (ja) | ウマ科動物の羊水由来の多分化能幹細胞及びそれを製造する方法 | |
CN104403988B (zh) | 一种诱导小鼠胚胎干细胞分化内耳毛细胞的方法 | |
CN102154195B (zh) | 一种山羊雄性生殖干细胞的体外分离及培养方法 | |
CN104140951B (zh) | 一种建立和培养人诱导多能干细胞的方法 | |
CN103305459A (zh) | 小分子诱导猪精原干细胞转变为胚胎干细胞样细胞的方法 | |
CN111304167B (zh) | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 | |
CN104774803B (zh) | 新的胚胎干细胞培养体系及胚胎干细胞建系方法 | |
CN104130975B (zh) | 人源脂肪干细胞来源的神经元样细胞及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI DECAI Free format text: FORMER OWNER: CHUNG HSING UNIVERSITY Effective date: 20130927 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130927 Address after: Taiwan Guoguang Chinese Taichung City Road No. 250 Applicant after: Li Decai Address before: Taiwan Guoguang Chinese Taichung City Road No. 250 Applicant before: National Chung Hsing University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180124 Address after: Taichung City, Taiwan, China Patentee after: Hongyan biotech Co. Ltd. Address before: Taiwan Guoguang Chinese Taichung City Road No. 250 Patentee before: Li Decai |
|
TR01 | Transfer of patent right |